换一批
换一批Early magnesium reduction in advanced colorectal cancer patients treated with cetuximab plus irinotecan as predictive factor of efficacy and outcome.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);喜树碱(Camptothecin);结直肠肿瘤(Colorectal Neoplasms);疾病恶化(Disease Progression);女(雌)性(Female);基因表达调控, 肿瘤(Gene Expression Regulation, Neoplastic);人类(Humans);镁(Magnesium);男(雄)性(Male);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);治疗结果(Treatment Outcome)
DOI
10.1158/1078-0432.CCR-08-0077
PMID
18594003
发布时间
2022-04-19
- 浏览34
Clinical cancer research
4219-24页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
